{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:19:35Z","timestamp":1769433575834,"version":"3.49.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T00:00:00Z","timestamp":1193184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001052","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T21:04:19Z","timestamp":1193173459000},"page":"e1052","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials"],"prefix":"10.1371","volume":"2","clinical-trial-number":[{"clinical-trial-number":"nct00480714","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00427830","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00427453","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ansar A.","family":"Pathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare R.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen A.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Poulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola C.","family":"Alder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie E. R.","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn T.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,10,24]]},"reference":[{"key":"ref1","article-title":"The Global Plan to stop TB 2006\u20132015","author":"ST Partnership","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature [see comments].","volume":"271(9)","author":"GA Colditz","year":"1994","journal-title":"Jama"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.","volume":"22(6)","author":"LC Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367(9517)","author":"BB Trunz","year":"2006","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.","volume":"366(9493)","author":"LC Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis.","volume":"19","author":"JL Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.","volume":"178(6)","author":"JL Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.","volume":"364(9451)","author":"SE Dorman","year":"2004","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/nm1221","article-title":"Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.","volume":"11","author":"SH Kaufmann","year":"2005","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.","volume":"30(12)","author":"LA van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.","volume":"4(4)","author":"J Schneider","year":"1998","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1128\/JVI.73.9.7524-7532.1999","article-title":"Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.","volume":"73(9)","author":"T Hanke","year":"1999","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.","volume":"69(2)","author":"H McShane","year":"2001","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.","volume":"10(11)","author":"H McShane","year":"2004","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":". Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.","volume":"70(3)","author":"H McShane","year":"2002","journal-title":"Infect Immun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/IAI.00590-06","article-title":"A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.","volume":"74(10)","author":"SJ Dunachie","year":"2006","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.vaccine.2005.08.041","article-title":"Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.","volume":"24(4)","author":"I Cebere","year":"2006","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2249.2003.02272","article-title":"Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.","volume":"134(2)","author":"RE Weir","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1016\/j.vaccine.2006.04.037","article-title":"Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine.","volume":"24(29\u201330)","author":"P Gorak-Stolinska","year":"2006","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(05)17702-2","article-title":"Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.","volume":"365(9454)","author":"HJ Zar","year":"2005","journal-title":"Lancet"},{"key":"ref21","first-page":"1212","article-title":"Should HPV vaccines be mandatory for all adolescents?","volume":"368(9543)","year":"2006","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1371\/annotation\/71208a01-eb32-469c-96ab-8d5e3c497fce","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T00:00:00Z","timestamp":1298678400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T10:13:41Z","timestamp":1587982421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001052"}},"subtitle":[],"editor":[{"given":"James","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,24]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,10,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001052","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/71208a01-eb32-469c-96ab-8d5e3c497fce","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,24]]}}}